Edition:
United States

Rosetta Genomics Ltd (ROSG.OQ)

ROSG.OQ on NASDAQ Stock Exchange Capital Market

0.73USD
17 Nov 2017
Change (% chg)

$-0.09 (-10.98%)
Prev Close
$0.82
Open
$0.83
Day's High
$0.85
Day's Low
$0.72
Volume
55,572
Avg. Vol
43,296
52-wk High
$9.60
52-wk Low
$0.63

Chart for

About

Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next... (more)
No analyst recommendations are available for .

Overall

Beta: 0.37
Market Cap(Mil.): $2.26
Shares Outstanding(Mil.): 3.09
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 197.02 15.79
EPS (TTM): -- -- --
ROI: -- -10.12 12.01
ROE: -- -37.71 15.91

BRIEF-Morgan Stanley reports 5.1 pct passive stake in Rosetta Genomics

* Morgan stanley reports 5.1 percent passive stake in Rosetta Genomics as of May 23, 2017 - ‍​SEC filing Source text for Eikon: Further company coverage:

Jun 02 2017

Earnings vs. Estimates